Browsing Category
Pharmaceuticals
Alembic Pharmaceuticals Limited announces USFDA Final Approval for Loteprednol…
December: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug!-->…
Sun Pharma concludes SUN PRISM 2025, a National B-school Competition
MUMBAI: Sun Pharmaceutical Industries Limited (Sun Pharma), India’s No. 1 pharmaceutical company by revenues and prescriptions1, concluded the grand finale of SUN PRISM 2025, its flagship!-->…
Mankind Pharma expands PetStar portfolio with launch of PetStar Delight cat food…
Bengaluru: Mankind Pharma, one of India's leading pharmaceutical companies, today announced the launch of PetStar Delight, expanding its PetStar brand into the cat food segment. The new!-->…
SAI Parenteral’s Ltd. Acquires Australia’s Noumed Pharmaceuticals for INR…
Hyderabad: SAI Parenteral's Limited (SPL), a diversified pharmaceutical formulation company, today announced the acquisition of a 74.6% controlling stake in Noumed Pharmaceuticals Pty Ltd,!-->…
CPHI & PMEC India Uniting over 50,000 Professionals and Global Leaders to Shape…
New Delhi: The 18th edition of CPHI & PMEC India, organised by Informa Markets in India, commenced at the India Expo Centre, Greater Noida, Delhi-NCR, showcasing the robust potential of!-->…
Zydus receives final approval from USFDA for Verapamil Hydrochloride Extended-Release…
Bengaluru: Zydus Lifesciences Limited (including its subsidiaries/ affiliates, hereafter referred to as “Zydus”) has received final approval from the United States Food and Drug!-->…
Global Pharmaceutical Leaders from 7 Countries Attend Galgotias’ International…
Greater Noida: The 2nd PHARMAINNOVATE SUMMIT 2025 an International Conference on “From Molecule to Medicine: Drug Development, Drug Delivery & Life-Saving Therapies” was!-->…
Actimed Therapeutics announces important licensing agreement with Mankind Pharma
Bengaluru : Actimed Therapeutics Ltd, a UK based clinical stage specialty pharmaceutical company focused on bringing innovation to the treatment of cancer cachexia and other muscle wasting!-->…
Sudeep Pharma Limited’s Rs 895 crore Initial Public Offering to open on Friday,…
Mumbai: Sudeep Pharma Limited has fixed the price band of ₹ 563- to ₹ 593 - per Equity Share of face value ₹1/- each for its maiden initial public offer.
The Initial Public!-->!-->!-->…
Pfizer Launches New Rimegepant Oral Medication in India for Rapid Migraine Relief[i]…
Bangalore: Pfizer has announced the launch of a Rimegepant ODT in India for acute treatment of migraine, with or without aura, in adults with a previous insufficient response to triptan.!-->…